Rosa and FOCUS-IP Announce Strategic Alliance for Enhancing Proof-of-Concept Drug Development and Licensing Opportunities

Alliance combines innovative exploratory study design, leading in silico drug development capabilities, and a global licensing network to increase the value of emerging company portfolios and address pipeline gaps for established drug manufacturers.

<- Zurück zu: News archive